KATRINA MICHALIK: Open Payments
NPI 1629759543 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 24 payments from 9 companies in 2025. Trend: 2023 $139 · 2024 $2,759 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $216 |
| GlaxoSmithKline, LLC. | 6 | $186 |
| Eisai Inc. | 2 | $132 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Exelixis Inc. | 1 | $125 |
| Syndax Pharmaceuticals, Inc. | 1 | $84 |
| ABBVIE INC. | 4 | $67 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Acera Surgical, Inc. | 1 | $21 |
Products named: JEMPERLI, Lenvima, OPDIVO, CABOMETYX, REVUFORJ, ELAHERE, LYNPARZA, ZEJULA.
Industry payments across NJ — which companies pay providers there.
